Seven months ago, Renovia made some significant strides because the Food and (Drug Administration) approved Leva. The product satisfied the board and this has been the tradition of Marc Beer led the company for the last couple of years. The recent approvals cement the Renovia position in this niche. Due to adherence to set laws, the company has been able to gain the image of a viable investment option by various investors in the medical niche. In the past 12 months, the company has received over $42 million worth of funding from investors satisfied with the company’s direction.
According to the CEO, the funding is timely. Mark Beer is certain that sharing the company’s vision with investors will only strengthen the company’s ability to continue improving women health. Mark Beer has also been passionate about raising the standards of women health. Women health, specifically reproductive health has been part of his life as a professional. His determination in providing the best diagnosis approach, treatment procedure, and medicine indicates Mark Beer dynamism in this medical niche. In just two years in operation, the Miami University graduate has done what other investors have failed in that short span.
Apart from having passion in providing a solution to women health, Mark Beer is one of the best professional organizers and CEOs in organizational skills. With only two years in operation, he has been able to bring together the best brains in the medical world. The first professional he brought on board was William Dull. Dull is an expert in supervising medical companies and overseeing their profitability ventures. Due to the company’s need to be the trendsetter in innovation and research, Mark Beer also introduced one of the best researchers in women health, José Bohorquez. In that short span, the Ph.D. holder has brought a lot of dynamism treatment design.
Another reason why investors were willing to invest in Mark Beer’s dream was his experience in this particular field. Before founding Renovia, he was part of similar entities, which focused on women reproduction health. Some of the organization Beer worked for include Abbott Laboratories, which is (now) a public traded company and Good Start Genetics. The latter was his brainchild. He, however, sold the controlling shares to concentrate on Renovia. This vast experience in the medical world and his experience in setups was also part of the considerations the investors considered. In all the previous companies Mark Beer worked for had the same model as Renovia and therefore the future of this company according to investors can only be great. Learn more: https://www.slideshare.net/MarcBeer
In addition to his vision, his experience, and his organizational skills, Beer has unmatched leadership skills which many pundits have termed as natural. He has always been able to make strides in the medical world without losing commercial control of the company.